Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases, today announced the first patient...

FranklinWH Announces General Availability of Whole Home Energy Management System Featuring 15 kWh aPower 2 Battery and 15-Year Warranty

FranklinWH Announces General Availability of Whole Home Energy Management System Featuring 15 kWh aPower 2 Battery and 15-Year Warranty

SAN JOSE, Calif., Jan. 2, 2025 /PRNewswire/ -- FranklinWH Energy Storage Inc. (FranklinWH), a leader in whole-home energy management, today announced the general availability of its next-generation whole home energy management solutions, including...

Breaking Barriers and Building Futures: HR Asia's Best Companies to Work for in 2024 Malaysia Announced

Breaking Barriers and Building Futures: HR Asia's Best Companies to Work for in 2024 Malaysia Announced

KUALA LUMPUR, Malaysia, Jan. 2, 2025 /PRNewswire/ -- HR Asia, the leading publication in the human resources industry, announces the winners of its prestigious HR Asia Best Companies to Work for in Asia 2024. This year, a total of 66 outstanding...

TESSAN x Rachael Yamagata: Inspiring Charging Moments of Innovation and Connection

TESSAN x Rachael Yamagata: Inspiring Charging Moments of Innovation and Connection

NEW YORK, Jan. 2, 2025 /PRNewswire/ -- As the new year unfolds, the leading charging solution brand TESSAN proudly announces an inspiring collaboration with the American singer-songwriter Rachael Yamagata. Together, they are embarking on a journey...

A SPAC III Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on January 3, 2025

A SPAC III Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on January 3, 2025

HONG KONG, Jan. 1, 2025 /PRNewswire/ -- A SPAC III Acquisition Corp. (the "Company"), a blank check company incorporated as a British Virgin Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition,...

ZEEKR Announces December and Full Year 2024 Delivery Update

ZEEKR Announces December and Full Year 2024 Delivery Update

HANGZHOU, China, Jan. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("ZEEKR" or the "Company") (NYSE: ZK), a global premium electric mobility technology company, today announced its delivery results for December and the full...

Boqii Announces Fiscal 2025 First Half Unaudited Financial Results

Boqii Announces Fiscal 2025 First Half Unaudited Financial Results

SHANGHAI, Jan. 1, 2025 /PRNewswire/ -- Boqii Holding Limited ("We," "Boqii" or the "Company") (NYSE American: BQ), a leading pet-focused platform in China, today announced its unaudited financial results for the first half of fiscal 2025 (i.e., the...

EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

CHANGZHOU, China, Jan. 1, 2025 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider in China, today announced that the Company had received a notification letter...

MicroAlgo Inc. Announces the Launch of FULL Adder Operation Quantum Algorithm Technology Based on CPU Registers in Quantum Gate Computing

MicroAlgo Inc. Announces the Launch of FULL Adder Operation Quantum Algorithm Technology Based on CPU Registers in Quantum Gate Computing

SHENZHEN, China, Dec. 31, 2024 /PRNewswire/ -- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the successful development of a groundbreaking quantum algorithm technology, specifically a FULL adder operation based on...

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

SHANGHAI, Dec. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the initiation of an...

  • 1
  • ...
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • ...
  • 48
  • menu
    menu